peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
Your cost depends on your treatment plan, set at your free consultation
L-carnitine, the main ingredient of the product, is a compound naturally produced by the human body and consisting partly of amino acids
B-2 Vitamin B2 uses include increasing energy levels
Adding magnesium into the mix has also been associated with reduced muscle cramping and enhanced athletic performance (7)
Please note: Ingredient nomenclature may be updated to reflect exact supplier INCI documentation
.jpg)
